Literature DB >> 8400319

Response to P.M. Ravdin (BCRT 24:219-226, 1993), "Evaluation of Cathepsin D as a Prognostic Factor in Breast Cancer".

H Rochefort, S Thorpe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8400319     DOI： 10.1007/bf00682706

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  15 in total

1.  Breast cancer prognostic factors: evaluation guidelines.

Authors:  W L McGuire
Journal:  J Natl Cancer Inst       Date:  1991-02-06       Impact factor: 13.506

2.  Cathepsin D: an independent prognostic factor for metastasis of breast cancer.

Authors:  F Spyratos; T Maudelonde; J P Brouillet; M Brunet; A Defrenne; C Andrieu; K Hacene; A Desplaces; J Rouëssé; H Rochefort
Journal:  Lancet       Date:  1989-11-11       Impact factor: 79.321

3.  Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness.

Authors:  J P Brouillet; C Theillet; T Maudelonde; A Defrenne; J Simony-Lafontaine; J Sertour; H Pujol; P Jeanteur; H Rochefort
Journal:  Eur J Cancer       Date:  1990-04       Impact factor: 9.162

Review 4.  Evaluation of cathepsin D as a prognostic factor in breast cancer.

Authors:  P M Ravdin
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

5.  Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: low correlation with other prognostic parameters.

Authors:  T Maudelonde; S Khalaf; M Garcia; G Freiss; J Duporte; M Benatia; H Rogier; F Paolucci; J Simony; H Pujol
Journal:  Cancer Res       Date:  1988-01-15       Impact factor: 12.701

6.  Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays.

Authors:  T E Kute; Z M Shao; N K Sugg; R T Long; G B Russell; L D Case
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

Review 7.  The future of prognostic factors in outcome prediction for patients with cancer.

Authors:  L P Fielding; C M Fenoglio-Preiser; L S Freedman
Journal:  Cancer       Date:  1992-11-01       Impact factor: 6.860

8.  A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol.

Authors:  P Pujol; T Maudelonde; J P Daures; P Rouanet; J P Brouillet; H Pujol; H Rochefort
Journal:  Cancer       Date:  1993-03-15       Impact factor: 6.860

9.  Characterization of monoclonal antibodies to the estrogen-regulated Mr 52,000 glycoprotein and their use in MCF7 cells.

Authors:  M Garcia; F Capony; D Derocq; D Simon; B Pau; H Rochefort
Journal:  Cancer Res       Date:  1985-02       Impact factor: 12.701

10.  Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.

Authors:  S M Thorpe; H Rochefort; M Garcia; G Freiss; I J Christensen; S Khalaf; F Paolucci; B Pau; B B Rasmussen; C Rose
Journal:  Cancer Res       Date:  1989-11-01       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.